COVILIV Trademark

Trademark Overview

On Saturday, January 15, 2022, a trademark application was filed for COVILIV with the United States Patent and Trademark Office. The USPTO has given the COVILIV trademark a serial number of 97221377. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, January 21, 2025. This trademark is owned by Codagenix, Inc.. The COVILIV trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; pharmaceutical products for the treatment of viral and infectious diseases
coviliv

General Information

Serial Number97221377
Word MarkCOVILIV
Filing DateSaturday, January 15, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, January 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2022

Trademark Statements

Goods and ServicesVaccines; pharmaceutical products for the treatment of viral and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCodagenix, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFarmingdale, NY 11735
Party NameCodagenix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFarmingdale, NY 11735

Trademark Events

Event DateEvent Description
Monday, October 24, 2022ASSIGNED TO EXAMINER
Wednesday, January 19, 2022NEW APPLICATION ENTERED
Friday, January 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 30, 2023SOU EXTENSION 2 FILED
Monday, October 30, 2023SOU EXTENSION 2 GRANTED
Wednesday, November 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 22, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 12, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, July 12, 2023SOU EXTENSION 1 FILED
Wednesday, July 12, 2023SOU EXTENSION 1 GRANTED
Monday, October 30, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 22, 2024SOU EXTENSION 3 FILED
Monday, July 22, 2024SOU EXTENSION 3 GRANTED
Tuesday, January 21, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, January 21, 2025SOU EXTENSION 4 FILED
Wednesday, January 22, 2025SOU EXTENSION 4 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

coviliv infectious diseases viral treatment pharmaceutical products vaccines